Supriya S. Keshry

Bhubaneshwar, OR, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Optimum level of NEDD4 and its interaction with nsP3 are crucial to facilitate efficient Chikungunya virus (CHIKV) infection.

Optimum level of NEDD4 and its interaction with nsP3 are crucial to facilitate efficient Chikungunya virus (CHIKV) infection.

Journal: The Journal of general virology
Published: August 11, 2025

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2.

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2.

Journal: Scientific reports
Published: June 23, 2023

TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.

TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.

Journal: Frontiers in immunology
Published: January 07, 2023

DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication.

DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication.

Journal: Journal of virology
Published: November 15, 2022

Versatile β-Catenin Is Crucial for SARS-CoV-2 Infection.

Versatile β-Catenin Is Crucial for SARS-CoV-2 Infection.

Journal: Microbiology spectrum
Published: August 31, 2022

MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo.

MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo.

Journal: Antimicrobial agents and chemotherapy
Published: June 29, 2022

Plants extracts from Cameroon pharmacopeia strongly inhibit the Chikungunya virus infection by targeting entry and replication steps.

Plants extracts from Cameroon pharmacopeia strongly inhibit the Chikungunya virus infection by targeting entry and replication steps.

Journal: Journal of ethnopharmacology
Published: April 19, 2022

Isolation and Characterization of Five Severe Acute Respiratory Syndrome Coronavirus 2 Strains of Different Clades and Lineages Circulating in Eastern India.

Isolation and Characterization of Five Severe Acute Respiratory Syndrome Coronavirus 2 Strains of Different Clades and Lineages Circulating in Eastern India.

Journal: Frontiers in microbiology
Published: January 17, 2022

Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways.

Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways.

Journal: Antimicrobial agents and chemotherapy
Published: November 08, 2021

Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.

Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.

Journal: Frontiers in cellular and infection microbiology
Published: June 14, 2021

MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.

MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.

Journal: PLoS pathogens
Published: May 18, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026